HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of cholinesterase inhibitors and serotonin-1A receptor agonists on morphine-induced ventilatory depression and antinociception in rats.

Abstract
Ventilatory depression is a serious side-effect of opioid analgesics. Naloxone, an antagonist of opioid receptors, eliminates not only ventilatory depression but also analgesic effect of opioids. Pharmacological dissociation of adverse reactions from the main action is important clinically and basically. Cholinergic and serotonergic mechanisms are suggested to counteract the opioid-induced ventilatory disturbances, but their influence on analgesia is still controversial. The present study evaluated the effects of cholinesterase inhibitors and serotonin-1A (5-HT1A) receptor agonists on morphine (1.0mg/kg, i.v.)-induced ventilatory depression and analgesia in rats. In anesthetized animals, spontaneous ventilation and hind leg withdrawal reflexes against nociceptive thermal stimuli were measured simultaneously. Physostigmine (0.1 and 0.2mg/kg, i.v.) and donepezil (0.5 and 1.0mg/kg, i.v.) relieved the morphine-induced ventilatory depression and enhanced its antinociception. On the other hand, (±)-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT, 0.03 and 0.1mg/kg, i.v.) and buspirone (0.1 and 0.3mg/kg, i.v.) did not influence antinociception of morphine while they restored the decreased ventilation. In unanesthetized animals, hypercapnic ventilatory response was measured by using whole-body plethysmography. Physostigmine (0.3mg/kg, i.p.), donepezil (1.0mg/kg, i.p.), 8-OH-DPAT (0.3mg/kg, i.p.) and buspirone (3.0mg/kg, i.p.) all recovered the morphine (10mg/kg, i.p.)-induced depression of hypercapnic ventilatory response. The present study suggests that activation of cholinergic or serotonergic (5-HT1A) mechanisms may be a useful therapeutic approach for morphine-induced ventilatory depression without loss of its analgesic action.
AuthorsSatoko Kimura, Yoshiaki Ohi, Akira Haji
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 703 Issue 1-3 Pg. 33-41 (Mar 05 2013) ISSN: 1879-0712 [Electronic] Netherlands
PMID23438874 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Cholinesterase Inhibitors
  • Indans
  • Piperidines
  • Serotonin 5-HT1 Receptor Agonists
  • Morphine
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Donepezil
  • Physostigmine
  • Buspirone
Topics
  • 8-Hydroxy-2-(di-n-propylamino)tetralin (pharmacology)
  • Analgesia
  • Animals
  • Buspirone (pharmacology)
  • Cholinesterase Inhibitors (pharmacology)
  • Donepezil
  • Indans (pharmacology)
  • Male
  • Morphine
  • Pain (drug therapy)
  • Physostigmine (pharmacology)
  • Piperidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Respiratory Insufficiency (chemically induced, drug therapy)
  • Serotonin 5-HT1 Receptor Agonists (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: